Aardvark Therapeutics (AARD) Other Operating Expenses (2024)
Aardvark Therapeutics (AARD) reported Other Operating Expenses of $14000.0 for Q2 2024, down 86.41% sequentially from $103000.0 in Q1 2024.
Aardvark Therapeutics (AARD) Other Operating Expenses (2024) Analysis & Trends
Aardvark Therapeutics (AARD) has 1 years of Other Operating Expenses data on file, last reported at $14000.0 in Q2 2024.
- For the quarter ending Q2 2024, Other Operating Expenses changed N/A year-over-year to $14000.0; the trailing twelve-month figure through Mar 2025 stood at $14000.0 (changed N/A YoY), and the FY2024 full-year result was $117000.0, changed N/A from the prior year.
- Other Operating Expenses eased to $14000.0 in Q2 2024, from $103000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $103000.0 in Q1 2024 to a low of $14000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 103,000.00 |